Clinical Trial Update: Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)

View source ↗

Summary

This clinical trial update summarizes the completed study of Osteocel Plus used in transforaminal lumbar interbody fusion for degenerative disc disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Osteocel Plus

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease | Status: COMPLETED